Preclinical testing of active substances and cancer research

摘要

The current issue focuses on current development for the production of anti-cancer molecules, principles and evaluation of factors associated with cancer risk, diagnostics and therapy, taking into consideration that cancer is a diverse disease with complex pathobiology. The papers for this hot topic issue have been received from the scientific conference which was held in Kragujevac, Serbia (March 16-19,2011) entitled "PRECLINICAL TESTING OF ACTIVE SUBSTANCES AND CANCER RESEARCH" with an internationally recognized symposium on "ANTI-CANCER AGENTS, CARDIOTOXICITY AND NEUROTOXICITY".